Status

Total

(n = 300)

Alive

(n = 200; 68%)

Death

(n = 100; 33%)

n (%)

n (%)

n (%)

p

OR

IC 95%

Age, mean (sd)

59 (17)

56 (17)

63 (16)

0.001‡

1.026

1.011

1.042

Gender female

122 (41)

89 (45)

33 (33)

0.056*

0.614

0.372

1.014

Surgical patients

91 (30)

67 (34)

24 (24)

0.092*

0.627

0.364

1.081

SAPS II, mean (sd)

48 (16)

44 (15)

55 (15)

<0.001‡

1.051

1.032

1.070

Comorbidities

89 (30)

52 (26)

37 (37)

0.049*

1.672

0.999

2.796

Imunossupression

24 (8)

13 (7)

11 (11)

0.176*

1.778

0.766

4.125

Chronic hepatic disease

13 (4)

5 (3)

8 (8)

0.036**

3.391

1.080

10.652

Chronic renal disease

23 (8)

17 (9)

6 (6)

0.443*

0.687

0.262

1.801

Chronic heart failure

18 (6)

12 (6)

6 (6)

1.000*

1.000

0.364

2.748

Chronic respiratory

22 (7)

14 (7)

8 (8)

0.754*

1.155

0.468

2.853

Heaemathologic disease

5 (2)

1 (1)

4 (4)

0.044*

8.292

0.914

75.192

Cancer

5 (2)

1 (1)

4 (4)

0.044*

8.292

0.914

75.192

Station

Spring

76 (25)

49 (25)

27 (27)

0.488*

1.000

-

Summer

51 (17)

36 (18)

15 (15)

0.756

0.352

1.623

Autumn

63 (21)

46 (23)

17 (17)

0.671

0.324

1.389

Winter

110 (37)

69 (35)

41 (41)

1.078

0.587

1.981

Pneumonia

171 (57)

115 (58)

56 (56)

0.805*

0.941

0.580

1.527

Abdominal

69 (23)

46 (23)

23 (23)

1.000*

1.000

0.565

1.769

UTI

24 (8)

18 (9)

6 (6)

0.367*

0.645

0.248

1.680

Other focus

24 (8)

12 (6)

12 (12)

0.071*

2.136

0.923

4.945

Septic shock

202 (67)

117 (59)

85 (85)

<0.001*

4.020

2.169

7.449

Microbiological documented

168 (56)

114 (57)

54 (54)

0.622*

0.886

0.546

1.435

Positive blood cultures

59 (20)

33 (17)

26 (26)

0.051*

1.778

0.993

3.183

Polimicrobian

20 (7)

14 (7)

6 (6)

0.743*

0.848

0.316

2.278

Type of microorganism

Gram negative

62 (37)

45 (39)

17 (32)

0.602*

1.000

-

Gram positive

71 (42)

46 (40)

25 (46)

1.439

0.686

3.017

Other

35 (21)

23 (20

12 (22)

1.381

0.565

3.375

ESKAPE

19 (11)

10 (9)

9 (17)

0.290*

1.001

0.996

1.006